07. May 2015

By Lisa Tan - Associate VP Science and Regulatory Affairs at Generic Pharmaceutical Association As industry and the Agency enter into the third year of the generic drug user fee program, industry is still plagued with outstanding questions and concerns regarding the current and future state of the IID. I was invited by IPEC-Americas to present at the 2015 ExcipientFest held in San Juan, PR an industry prescriptive on the IID...bridging the past, current, and possible future state of the IID....